Consonance Capital Management LP / KROS
Consonance Capital Management LP’s Keros Therapeutics Inc Position
Does Consonance Capital Management LP own Keros Therapeutics Inc (KROS)? Not currently — the last reported position was 887.9K shares worth $38M in Q2 2021; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$38M
Q2 2021
Shares
887.9K
% of Portfolio
+4.54%
Quarters Held
3
position exited
Position History KROS
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of KROS.